Ministry of Chemicals and Fertilizers : press release · 13 March 2026 · pibtracker filter

Sale of Spurious Drugs

PRID2239582 MinistryMinistry of Chemicals and Fertilizers : Released Reading12 min

Posted On: 13 MAR 2026 3:52PM by PIB Delhi As per the information provided by Department of Health and Family Welfare manufacture/sales/distribution of Spurious/ Adulterated/Not of Standard Quality drugs etc. is a punishable offence under the Drugs & Cosmetics Act, 1940 and the Drugs Rules, 1945 and concerned licensing authorities are empowered to take action in such cases. As per the information provided by Department of Health and Family Welfare, Central Drugs Standard Control Organization (CDSCO) as well as State Drugs Control Authorities draw samples of drugs for test and analysis from supply chain under the provisions of Drugs and Cosmetics Act, 1940 and Rules thereunder. All the drug samples found not of standard quality/spurious/ adulterated by the Central Govt. Laboratory and reports of Not of Standard Quality (NSQ)/spurious /adulterated forwarded by the State Drugs Controllers to CDSCO are uploaded on the website of CDSCO as part of the monthly drug alerts to make it available publicly. In such cases, the manufacturers (as per the label claim) are directed to recall such drugs and based on investigation outcomes, actions are taken by the concerned licensing authorities under the provisions of Drugs & Cosmetics Act & rules made thereunder. The number of drugs banned by Central Government under the provisions of Drugs & Cosmetics Act, year wise is as follows: Year No. of Drugs Banned 2021 NIL 2022 NIL 2023 14 for human use and 02 drugs for animal use 2024 157 for human use and 01 drug for animal use 2025 01 human use and 36 drugs for animal use Further, under the Drugs and Cosmetics Act, 1940, the manufacture, sale, or distribution of spurious drugs is strictly prohibited. According to Section 17B, a drug is considered spurious if it is manufactured under the name of another drug, is an imitation intended to deceive, bears a false manufacturer’s name, claims to be produced by a non-existent manufacturer, or has been wholly or partly substituted with another substance. Section 18 prohibits the manufacture, sale, stocking, or distribution of such drugs without proper authorization. The Drugs and Cosmetics Rules, 1945 support these provisions by regulating licensing, labeling, inspection, and manufacturing standards to prevent the production of counterfeit medicines. Punishment for manufacturing or selling spurious drugs is provided under Section 27 of the Act. If the spurious drug causes death or grievous hurt, the offender may face imprisonment of not less than 10 years, which may extend to life imprisonment, along with a fine of at least ₹10 lakh or three times the value of the drugs confiscated. In other cases, the punishment includes imprisonment of not less than 7 years, which may extend to life imprisonment, along with a minimum fine of ₹3 lakh or three times the value of the drugs. Additionally, under Sections 31 and 34, the drugs and related materials may be confiscated, and company officials responsible for the offence may also be held liable. Offences relating to spurious drugs are cognizable and non-bailable, ensuring strict enforcement against manufacturers of fake medicines. This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today. ***** PC/PM (Release ID: 2239582) Visitor Counter : 546 Read this release in: Urdu , हिन्दी , Telugu Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals Sale of Spurious Drugs Posted On: 13 MAR 2026 3:52PM by PIB Delhi As per the information provided by Department of Health and Family Welfare manufacture/sales/distribution of Spurious/ Adulterated/Not of Standard Quality drugs etc. is a punishable offence under the Drugs & Cosmetics Act, 1940 and the Drugs Rules, 1945 and concerned licensing authorities are empowered to take action in such cases. As per the information provided by Department of Health and Family Welfare, Central Drugs Standard Control Organization (CDSCO) as well as State Drugs Control Authorities draw samples of drugs for test and analysis from supply chain under the provisions of Drugs and Cosmetics Act, 1940 and Rules thereunder. All the drug samples found not of standard quality/spurious/ adulterated by the Central Govt. Laboratory and reports of Not of Standard Quality (NSQ)/spurious /adulterated forwarded by the State Drugs Controllers to CDSCO are uploaded on the website of CDSCO as part of the monthly drug alerts to make it available publicly. In such cases, the manufacturers (as per the label claim) are directed to recall such drugs and based on investigation outcomes, actions are taken by the concerned licensing authorities under the provisions of Drugs & Cosmetics Act & rules made thereunder. The number of drugs banned by Central Government under the provisions of Drugs & Cosmetics Act, year wise is as follows: Year No. of Drugs Banned 2021 NIL 2022 NIL 2023 14 for human use and 02 drugs for animal use 2024 157 for human use and 01 drug for animal use 2025 01 human use and 36 drugs for animal use Further, under the Drugs and Cosmetics Act, 1940, the manufacture, sale, or distribution of spurious drugs is strictly prohibited. According to Section 17B, a drug is considered spurious if it is manufactured under the name of another drug, is an imitation intended to deceive, bears a false manufacturer’s name, claims to be produced by a non-existent manufacturer, or has been wholly or partly substituted with another substance. Section 18 prohibits the manufacture, sale, stocking, or distribution of such drugs without proper authorization. The Drugs and Cosmetics Rules, 1945 support these provisions by regulating licensing, labeling, inspection, and manufacturing standards to prevent the production of counterfeit medicines. Punishment for manufacturing or selling spurious drugs is provided under Section 27 of the Act. If the spurious drug causes death or grievous hurt, the offender may face imprisonment of not less than 10 years, which may extend to life imprisonment, along with a fine of at least ₹10 lakh or three times the value of the drugs confiscated. In other cases, the punishment includes imprisonment of not less than 7 years, which may extend to life imprisonment, along with a minimum fine of ₹3 lakh or three times the value of the drugs. Additionally, under Sections 31 and 34, the drugs and related materials may be confiscated, and company officials responsible for the offence may also be held liable. Offences relating to spurious drugs are cognizable and non-bailable, ensuring strict enforcement against manufacturers of fake medicines. This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today. ***** PC/PM (Release ID: 2239582) <span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><span style="color:black">As per the information provided by Department of Health and Family Welfare manufacture/sales/distribution of Spurious/ Adulterated/Not of Standard Quality drugs etc. is a punishable offence under the Drugs &amp; Cosmetics Act, 1940 and the Drugs Rules, 1945 and concerned licensing authorities are empowered to take action in such cases. </span></span></span></p> <p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><span style="color:black">As per the information provided by Department of Health and Family Welfare, Central Drugs Standard Control Organization (CDSCO) as well as State Drugs Control Authorities draw samples of drugs for test and analysis from supply chain under the provisions of Drugs and Cosmetics Act, 1940 and Rules thereunder. All the drug samples found not of standard quality/spurious/ adulterated by the Central Govt. Laboratory and reports of Not of Standard Quality (NSQ)/spurious /adulterated forwarded by the State Drugs Controllers to CDSCO are uploaded on the website of CDSCO as part of the monthly drug alerts to make it available publicly. </span></span></span></p> <p style="text-align:justify"><span style="color:black; font-family:"Times New Roman",Times,serif; font-size:16px">In such cases, the manufacturers (as per the label claim) are directed to recall such drugs and based on investigation outcomes, actions are taken by the concerned licensing authorities under the provisions of Drugs &amp; Cosmetics Act &amp; rules made thereunder.</span></p> <p style="text-align:justify"><span style="font-family:"Times New Roman",Times,serif; font-size:16px">The number of drugs banned by Central Government under the provisions of Drugs &amp; Cosmetics Act, year wise is as follows:</span></p> <table align="center" border="1" bordercolor="#ccc" cellpadding="5" cellspacing="0" class="Table" style="border-collapse:collapse"> <tbody> <tr> <td rowspan="2" style="width:83.6pt"> <p style="margin-left:1.45pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><strong>Year</strong></span></span></p> </td> <td rowspan="2" style="width:264.15pt"> <p style="margin-left:.75pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><strong>No. of Drugs Banned</strong></span></span></p> </td> <td style="height:10.2pt">&nbsp;</td> </tr> <tr> <td style="height:7.75pt">&nbsp;</td> </tr> <tr> <td rowspan="2" style="width:83.6pt"> <p style="margin-left:1.45pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">2021</span></span></p> </td> <td rowspan="2" style="width:264.15pt"> <p style="margin-left:.75pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">NIL</span></span></p> </td> <td style="height:9.45pt">&nbsp;</td> </tr> <tr> <td style="height:8.5pt">&nbsp;</td> </tr> <tr> <td rowspan="2" style="width:83.6pt"> <p style="margin-left:1.45pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">2022</span></span></p> </td> <td rowspan="2" style="width:264.15pt"> <p style="margin-left:.75pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">NIL</span></span></p> </td> <td style="height:8.7pt">&nbsp;</td> </tr> <tr> <td style="height:9.25pt">&nbsp;</td> </tr> <tr> <td style="width:83.6pt"> <p style="margin-left:.9pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">2023</span></span></p> </td> <td style="width:264.15pt"> <p style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">14 for human use and 02 drugs for animal use</span></span></p> </td> <td style="height:19.7pt">&nbsp;</td> </tr> <tr> <td style="width:83.6pt"> <p style="margin-left:.9pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">2024</span></span></p> </td> <td style="width:264.15pt"> <p style="margin-left:.75pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">157 for human use and 01 drug for animal use</span></span></p> </td> <td style="height:20.8pt">&nbsp;</td> </tr> <tr> <td style="width:83.6pt"> <p style="margin-left:0cm; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">2025</span></span></p> </td> <td style="width:264.15pt"> <p style="margin-left:1.1pt; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">01 human use and 36 drugs for animal use</span></span></p> </td> <td style="height:21.85pt">&nbsp;</td> </tr> </tbody> </table> <p style="text-align:justify"><span style="color:black; font-family:"Times New Roman",Times,serif; font-size:16px">Further, under the Drugs and Cosmetics Act, 1940, the manufacture, sale, or distribution of spurious drugs is strictly prohibited. According to Section 17B, a drug is considered spurious if it is manufactured under the name of another drug, is an imitation intended to deceive, bears a false manufacturer’s name, claims to be produced by a non-existent manufacturer, or has been wholly or partly substituted with another substance. Section 18 prohibits the manufacture, sale, stocking, or distribution of such drugs without proper authorization. The Drugs and Cosmetics Rules, 1945 support these provisions by regulating licensing, labeling, inspection, and manufacturing standards to prevent the production of counterfeit medicines.</span></p> <p style="text-align:justify"><span style="color:black; font-family:"Times New Roman",Times,serif; font-size:16px">Punishment for manufacturing or selling spurious drugs is provided under Section 27 of the Act. If the spurious drug causes death or grievous hurt, the offender may face imprisonment of not less than 10 years, which may extend to life imprisonment, along with a fine of at least ₹10 lakh or three times the value of the drugs confiscated. In other cases, the punishment includes imprisonment of not less than 7 years, which may extend to life imprisonment, along with a minimum fine of ₹3 lakh or three times the value of the drugs. Additionally, under Sections 31 and 34, the drugs and related materials may be confiscated, and company officials responsible for the offence may also be held liable. Offences relating to spurious drugs are cognizable and non-bailable, ensuring strict enforcement against manufacturers of fake medicines.</span></p> <p style="text-align:justify"><span style="color:black; font-family:"Times New Roman",Times,serif; font-size:16px">This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today.</span></p> <p style="text-align:center">&nbsp;</p> <p style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><span style="color:black">*****</span></span></span></p> <p><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><span style="color:black">PC/PM</span></span></span></strong></p> " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //